Official Activities to Begin in November

The Ministry of Food and Drug Safety has been designated as the world’s first WHO Collaborating Center in the field of strengthening and training regulatory systems for medical products, as recognized by the World Health Organization (WHO). Going forward, it will serve as a global hub for enhancing regulatory capabilities by providing trainings related to pharmaceuticals and vaccines for regulatory officials from various countries.


Ministry of Food and Drug Safety Designated as World’s First WHO Regulatory Capacity Collaborating Center View original image

On September 2, the Global Harmonization Center (GHC) under the National Institute of Food and Drug Safety Evaluation, an affiliate of the Ministry of Food and Drug Safety, announced that it has been designated by WHO as a “WHO Collaborating Center for Strengthening and Training in the Field of Medical Product Regulatory Systems.” A WHO Collaborating Center is a specialized institution selected by the WHO to carry out international health projects in specific fields.


With this designation, GHC will operate under the official name “WHO Collaborating Center for Strengthening and Training in the Field of Medical Product Regulatory Systems” until July 29, 2030. The GHC will provide training for regulatory officials in WHO member states and support the improvement of each country’s regulatory systems and competencies. It will also participate in developing educational programs and methods for officials responsible for the regulation of pharmaceuticals and vaccines.


In November, GHC will officially launch its activities as a collaborating center by inviting officials from WHO headquarters and the Western Pacific Regional Office to an international workshop.



Oh Yu-kyoung, Minister of Food and Drug Safety, stated, “This designation as a WHO Collaborating Center reaffirms the regulatory capabilities of the Ministry of Food and Drug Safety and serves as recognition from the WHO of the significant role GHC has played in enhancing global regulatory systems. Working closely with WHO, we will play a pivotal role in narrowing regulatory gaps between countries.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing